Marco Tagliamento, Assistant Professor at University of Genoa, shared a post on X:
“In Annals of Oncology we discussed what might be the best platinum backbone in immunotherapy-containing regimens for lung cancer, including clinical and biological reasons.
Time to rethink platinum choices in the era of immunotherapy in lung cancer
Authors: E. Harris, N.F. Taflin, A. Chitkara, M. Tagliamento, C.M. Bestvina, C.V. Vakkalagadda, B. Besse,
